 Evogene Ltd. NASDAQ: EVGN TASE: EVGN.TA, a leading computational biology company targeting to revolutionize life-science product development across several market segments including ag-biologicals, ag-chemicals, human microbiome based therapies and medical cannabis, today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2nd at 9:40 AM ET. Ofer Haviv, Evogenes President and CEO will be presenting to a live audience. 